Ann: Letter to Shareholders, page-15

" It should raise the funds in a canter given the latest clinical trial results for its main drug BIT225, which produced the stunning result of all trial participants being clear of hepatitis C after 48 weeks when combined with existing treatments. "

Another classic example of the press getting it wrong..... and Michelle shouldn't have provided a link to such rubbish. Old story about the rights issue which says all trial participants were cleared at week 48. Trial participants include all trial participants, not just the ones who didn't drop out.

Also. There was never any SVR results for that trial. I can guess why.